Gavi’s 2016 round of applications for vaccines and health system strengthening support is now open.
When to apply
Applications will be accepted on a rolling basis. If a country misses a deadline, the application will be reviewed by the subsequent Independent Review Committee. An Expression of Interest is no longer a requirement for 2016 applications.
Deadline for application submission
15 January 2016
1 May 2016
9 September 2016
Application review dates (Independent Review Committee)
7-18 March 2016
17-24 June 2016
7-18 November 2016
Gavi Board/ CEO decision
by June 2016
by November 2016
by March 2017
How to apply - instructions
Countries must submit applications through Gavi’s online country portal, which will open two months ahead of submission deadlines. Log in details will be provided directly to each country’s focal point.
To guide their 2016 applications, countries must download four separate documents for each type of Gavi support. These guidelines and instructions should be read in the following order (see flow chart for more detail):
- General guidelines
- Support-specific guidelines
- Application instructions
- Application form
Click on the zip files below to download the full package of guidelines for each type of Gavi support. Alternatively, download individual documents using the table.
Independent Review Committee review criteria
Download the criteria which the IRC uses to review applications for all types of Gavi support.
Review criteria tailored to the relevant type of support are also provided in each of the support-specific guidelines.
Exceptional catalytic support
A supplementary set of guidelines is available for the time-limited opportunity to access exceptional catalytic support for the introduction of HPV, MR and/or JE vaccines for those countries that did not have the possibility to apply for these vaccines due to the timing of the vaccines’ availability.
Who to contact
For any questions regarding the application guidelines please contact email@example.com or the Gavi Senior Country Manager.